HF
MRNA icon

HRT Financial’s Moderna MRNA Stock Holding History

HRT Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Sell
10,900
-259,300
-96% -$12.1M ﹤0.01% 2445
2025
Q4 		$7.97M Sell
270,200
-190,400
-41% -$5.17M 0.03% 548
2025
Q3 		$11.9M Buy
460,600
+381,000
+479% +$10.6M 0.04% 332
2025
Q2 		$2.2M Sell
79,600
-24,400
-23% -$643K 0.01% 882
2025
Q1 		$2.95M Buy
+104,000
New +$3.69M 0.02% 649
2024
Q4 		– Sell
-37,100
Closed -$2.48M – 2935
2024
Q3 		$2.48M Buy
+37,100
New +$3.41M 0.01% 795
2024
Q1 		– Sell
-5,700
Closed -$566K – 2800
2023
Q4 		$566K Buy
5,700
+3,500
+159% +$294K ﹤0.01% 1292
2023
Q3 		$227K Sell
2,200
-6,300
-74% -$703K ﹤0.01% 1782
2023
Q2 		$1.03M Buy
+8,500
New +$1.13M 0.01% 931
2023
Q1 		– Sell
-1,800
Closed -$323K – 2929
2022
Q4 		$323K Buy
+1,800
New +$294K ﹤0.01% 1679
2022
Q2 		– Sell
-2,800
Closed -$482K – 3410
2022
Q1 		$482K Hold
2,800
– – ﹤0.01% 1868
2021
Q4 		$711K Buy
+2,800
New +$819K ﹤0.01% 1491
2021
Q3 		– Sell
-5,700
Closed -$1.34M – 3590
2021
Q2 		$1.34M Buy
+5,700
New +$1.02M 0.01% 842
2020
Q4 		– Sell
-14,700
Closed -$1.04M – 2229
2020
Q3 		$1.04M Buy
+14,700
New +$1.02M 0.03% 505

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's MRNA Position: Q1 2026 in Review

HRT Financial opened a new position in Moderna (MRNA) in Q1 2026: 368,421 shares worth $18.7M. The stake represents 0.05% of the portfolio and ranks #357 among its holdings. This is a return to the name: HRT Financial previously reported a position in MRNA as recently as Q3 2025.

HRT Financial first reported a position in MRNA in Q3 2020 and has held it in 11 quarters since. The position peaked at $140M in Q2 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • HRT Financial held 368,421 shares of Moderna worth $18.7M as of Q1 2026.
  • Moderna was a new HRT Financial position in Q1 2026.
  • Moderna made up 0.05% of HRT Financial's portfolio in Q1 2026, its #357 holding.
  • HRT Financial first reported a position in Moderna in Q3 2020 and has held it in 11 quarters since.
  • HRT Financial's Moderna position peaked at $140M in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.